Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

Most types of insulin therapy, an important part of diabetes treatment for many people, are given as daily injections to help manage blood sugar levels. Now, the maker of a once-weekly insulin ...

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...

Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- Awiqli(R) offers adults with type 2 diabetes an alternative to daily basal insulin ...

Share on Pinterest Eli Lilly’s once-weekly insulin injection is as effective as daily shots for managing blood sugar in diabetes, new data shows. Scott Olson/Getty Images New research offers an ...

Also known as juvenile-onset or insulin-dependent diabetes, this type of diabetes is not related to lifestyle and may occur ...

The UAB Comprehensive Diabetes Research Center is actively researching curative therapies for many types of diabetes. Learn more about the various types of diabetes below. Pre-diabetes is a condition ...

FDA approves 1st weekly basal insulin, Awiqli, offering adults with Type 2 diabetes a once-weekly injection to improve ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Insulin efsitora was noninferior to once-daily insulins ...